BSE filing, NSE: CRSTCHM. Summary written from the filing by ALFA Finder's alert engine.
Crestchem Ltd: key numbers
- Share price
- ₹142.10
- Market cap
- ₹42.63 Cr
- Revenue (annual)
- ₹29.61 Cr
- Net profit (annual)
- ₹2.71 Cr
- P/E (TTM)
- 12.7×Sector 34.5×
- Promoter holding
- 29.72%-0.04% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Crestchem Ltd
All →Crestchem Board Meeting Date
Crestchem Limited will hold a board meeting on November 5, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The agenda also allows other items with the Chair's permission.
Crestchem Price Movement Clarification
Crestchem Limited clarified that recent stock price movements are market-driven and not due to any undisclosed material information. The company confirmed compliance with all SEBI disclosure regulations.
Crestchem Other Announcement
Crestchem Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Crestchem Promoter Selling: ₹0.03 Cr
Crestchem Ltd promoters reported market transactions on September 10, 2026. Director Dipak Patel acquired 981 shares while Sonalben Patel sold 1,000 shares.
- Value
- ₹0.03 Cr
Crestchem Promoter Buying
Promoter Dipak Narendraprasad Patel acquired 200 equity shares of Crestchem Ltd via market purchase for ₹0.0026 Crore.
Crestchem Other Announcement
Crestchem Limited issued duplicate share certificates to one shareholder for three lost certificates covering 100 shares. This is a routine administrative filing with no financial impact.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.